SciClone Pharmaceuticals (SCLN) trades 10.7% lower premarket after the firm announces that its...

|About: SciClone Pharmaceuticals,... (SCLN)|By:, SA News Editor

SciClone Pharmaceuticals (SCLN) trades 10.7% lower premarket after the firm announces that its SCV-07 drug candidate failed to meet efficacy endpoints.